Clinical Trials Directory

Trials / Conditions / Advanced Solid Cancers

Advanced Solid Cancers

16 registered clinical trials studyying Advanced Solid Cancers — 6 currently recruiting.

StatusTrialSponsorPhase
RecruitingADCX-020 for the Treatment of Patients With Locally Advanced or Metastatic Cancers
NCT07238075
Adcytherix SASPhase 1
RecruitingExploratory Clinical Study of Targeted Activated DC and CAR-T Therapy in Advanced Solid Cancers
NCT07475182
Hainan Cancer HospitalEARLY_Phase 1
RecruitingA Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With
NCT07186842
BioNTech SEPhase 1 / Phase 2
RecruitingA Phase Ia/ Ib Study of HS387 in Subjects With Advanced Solid Tumors
NCT07092748
Zhejiang Hisun Pharmaceutical Co. Ltd.Phase 1
Active Not RecruitingExploratory Clinical Study on Memory NK Cell Therapy for Advanced Metastatic Solid Tumors
NCT07274449
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolPhase 1 / Phase 2
RecruitingStudy of SC-102 in Patients With Advanced Solid Tumors
NCT06710158
Tianjin ConjuStar Biologics Co., Ltd.Phase 1
RecruitingPhase II/III Trial of PRL3-Zumab in Advanced Solid Tumor Patients
NCT07290088
Intra-IMMUSG Pte LtdPhase 2 / Phase 3
CompletedAn Investigational Immunotherapy Study of BMS-986301 Alone or in Combination With Nivolumab, and Ipilimumab in
NCT03956680
Bristol-Myers SquibbPhase 1
CompletedStudy of SRF231 in Patients With Advanced Solid and Hematologic Cancers
NCT03512340
Surface OncologyPhase 1
TerminatedStudy ADI-PEG 20 Plus Pembrolizumab in Advanced Solid Cancers
NCT03254732
Polaris GroupPhase 1
Active Not RecruitingA Study of Investigational Drug CFI-402257 in Patients With Advanced Solid Tumors
NCT02792465
University Health Network, TorontoPhase 1
CompletedAGEN1884, an Anti-CTLA-4 Human Monoclonal Antibody in Participants With Advanced or Refractory Cancer and Who
NCT02694822
Agenus Inc.Phase 1 / Phase 2
CompletedPharmacokinetic Study of CKD-810 and Taxotere to Treat Patient With Advanced Solid Cancer
NCT01019941
Chong Kun Dang PharmaceuticalPhase 1
TerminatedA Study of BMS-863233 in Patients With Advanced and/or Metastatic Solid Tumors
NCT00886782
Bristol-Myers SquibbPhase 1 / Phase 2
CompletedOpioid Rotation Versus Combination for Chronic Uncontrolled Cancer Pain
NCT00478101
Gachon University Gil Medical CenterPhase 2
TerminatedA Study of the mTOR Inhibitor Rapamycin (Rapamune, Sirolimus) in Combination With Abraxane in Advanced Solid C
NCT00337376
Yale UniversityPhase 1